ArticleFrontiers in pharmacology2021

AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma.

Eslam E Abd El-Fattah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.